Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scil Technology was a German biopharmaceutical company specializing in the development of innovative products that bridge growth factors and biomaterials, with particular strengths in recombinant protein engineering and specific formulation technologies. Its lead programs targeted bone and cartilage repair, with clinical development reaching up to Phase III. The company also provided contract development, manufacturing, analytical, and formulation services to pharma/biotech partners. Notable partnerships included Medtronic for dental/bone regeneration and Sanofi for osteoarthritis/cartilage disorder therapies. Scil Technology was acquired by Nanohale[4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scil Technology.